Researchers from Clínic-IDIBAPS have participated in a Lancet Commission with international experts highlighting that more than 60% of liver cancer...
A Lancet Infectious Diseases perspective co-signed by Hospital Clínic and ISGlobal researchers argues that people in prison have the right to parti...
The journal The Lancet has published the results of a phase III clinical trial led by Josep Maria Llovet, from IDIBAPS-Hospital Clínic Barcelona. I...
A team from the Clínic-IDIBAPS, the Institute of Neurosciences UBNeuro and the University of Barcelona led by Yaroslau Compta has participated in a...
Bipolar disorder is a chronic psychiatric condition characterised by the recurrent appearance of episodes of mania and depression interspersed with...
An international study led by Clínic-IDIBAPS shows that the administration of individualised pulmonary ventilation strategies for each patient, adj...
Immune checkpoint inhibitors are a type of immunotherapy against cancer that activates the immune system to attack tumour cells. Although it is qui...
IDIBAPS researchers have reviewed the role of fibroblasts, a type of cell found in the liver, in the progression of liver cancer, both hepatocellul...
Researchers at the Hospital Clínic-IDIBAPS led an international study, published in the journal The Lancet, in which they designed an index to dete...
